Published in AIDS Weekly, May 26th, 1997
The vaccine, DROVAC, is made from the children's own blood cells. The disrupted cells are rolled up into shell-shaped spiral liposomes known as cochleates, which are administered orally.
Some of the children have been enrolled for two years in the first clinical trial of DROVAC.
"This preliminary therapeutic vaccine trial has demonstrated no adverse clinical or laboratory events, and [has shown] subjective clinical and objective laboratory evidence of stabilization and improvement of HIV disease status over a 20-month...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.